Novo Nordisk A/s Stock Forecast

Buy or Hold candidate since Jun 22, 2026 Gain 4.42%

The Novo Nordisk A/S stock price fell by -0.85% on the last day (Tuesday, 30th Jun 2026) from $48.34 to $47.93. During the last trading day the stock fluctuated 1.52% from a day low at $47.89 to a day high of $48.62. The price has been going up and down for this period, and there has been a 9.13% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -591 thousand shares and in total, 7 million shares were bought and sold for approximately $339.33 million.

The stock lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $48.48 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 21.98% during the next 3 months and, with a 90% probability hold a price between $52.62 and $59.14 at the end of this 3-month period.

NVO Signals & Forecast

The Novo Nordisk A/S stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $47.52 and $44.86. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 29, 2026, and so far it has fallen -0.85%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Novo Nordisk A/S stock

Novo Nordisk A/S finds support from accumulated volume at $45.76 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.728 between high and low, or 1.52%. For the last week, the stock has had daily average volatility of 1.97%.

The Novo Nordisk A/S stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $46.19 (-3.62%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 85 and this increases the risk substantially. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (NVO) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect Novo Nordisk A/S to open at $48.15, and during the day (based on 14 day Average True Range), to move between $47.27 and $48.59, which gives a possible trading interval of +/-$1.32 (+/-2.79%) up or down from last closing price. If Novo Nordisk A/S takes out the full calculated possible swing range there will be an estimated 2.79% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $48.03 (0.20%) than the support at $45.76 (4.53%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Novo Nordisk A/S stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Novo Nordisk A/S stock to perform well in the short-term.

Current score: 2.667 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 1, 2026 - $48.15 ( 0.451%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk